Oostpharma SRL
1.0 FTEThe score of Oostpharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -36 % Total assets -13 % Headcount (avg FTE) +100 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Oostpharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 50,468 € | ||||
| Equity | 243,303 € | ||||
| Cash | 67,613 € | ||||
| EBITDA | 105,404 € | ||||
| Total assets | 627,051 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 10 Jul 2026
- Year ended 31 Dec 2024filed on 16 Jul 2025
- Year ended 31 Dec 2023filed on 12 Jul 2024
- Year ended 31 Dec 2022filed on 20 Jul 2023
- Year ended 31 Dec 2021filed on 08 Jul 2022
Oostpharma's financial analysis
- Solvency38.8%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Oostpharma
Oostpharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0862.223.003
- VAT number
- BE0862223003
- Peppol
- Registered · 0208:0862223003 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 16 Dec 2003
- Registered office
- 9968 Assenede
- Size
- Micro · 1.0 FTE
- Latest accounts
- 2025 · filed on 10 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Oostpharma (SRL) has been based in Assenede since 2003, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 50,468 € and equity of 243,303 €; its revenue is not published. With 1.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 38.8%, below the median of its sector (44.2%).
Companies similar to Oostpharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmovan Retail sale of pharmaceutical products Leuven · balance sheet 626,313 €
- Pharmacie Apollo Retail sale of pharmaceutical products Schaerbeek · balance sheet 628,175 €
- Apotheek G. Moonen Retail sale of pharmaceutical products Sint-Pieters-Leeuw · balance sheet 625,839 €
- Accou Retail sale of pharmaceutical products Kuurne · balance sheet 629,386 €
- Hubert Pellegrin Retail sale of pharmaceutical products Uccle · balance sheet 623,769 €
- Bioclin Retail sale of pharmaceutical products Ostend · balance sheet 623,434 €
- Zichem Pharma Retail sale of pharmaceutical products Scherpenheuvel-Zichem · balance sheet 622,406 €
- MVA Pharma Retail sale of pharmaceutical products Charleroi · balance sheet 621,644 €
Frequently asked questions about Oostpharma
What is the revenue of Oostpharma?
Oostpharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Oostpharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0862223003 for Oostpharma, if the company is VAT-registered. Its company number (CBE) is 0862.223.003.
Where is the registered office of Oostpharma?
According to the CBE register, the registered office of Oostpharma is in 9968 Assenede.
What is the equity of Oostpharma?
At the close of the 2025 financial year, the equity of Oostpharma amounts to 243,303 €, a solvency of 38.8% of total assets.
How many people work at Oostpharma?
1.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Oostpharma?
The register lists 2 active mandates at Oostpharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Oostpharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →